Matches in Wikidata for { <http://www.wikidata.org/entity/Q81235405> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q81235405 description "article scientifique publié en 2005" @default.
- Q81235405 description "artículu científicu espublizáu en setiembre de 2005" @default.
- Q81235405 description "im September 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81235405 description "scientific article published on 19 September 2005" @default.
- Q81235405 description "wetenschappelijk artikel" @default.
- Q81235405 description "наукова стаття, опублікована у вересні 2005" @default.
- Q81235405 name "Phosphodiesterase inhibitors may be indicated in the treatment of postulated vasoactive neuropeptide autoimmune fatigue-related disorders" @default.
- Q81235405 name "Phosphodiesterase inhibitors may be indicated in the treatment of postulated vasoactive neuropeptide autoimmune fatigue-related disorders" @default.
- Q81235405 type Item @default.
- Q81235405 label "Phosphodiesterase inhibitors may be indicated in the treatment of postulated vasoactive neuropeptide autoimmune fatigue-related disorders" @default.
- Q81235405 label "Phosphodiesterase inhibitors may be indicated in the treatment of postulated vasoactive neuropeptide autoimmune fatigue-related disorders" @default.
- Q81235405 prefLabel "Phosphodiesterase inhibitors may be indicated in the treatment of postulated vasoactive neuropeptide autoimmune fatigue-related disorders" @default.
- Q81235405 prefLabel "Phosphodiesterase inhibitors may be indicated in the treatment of postulated vasoactive neuropeptide autoimmune fatigue-related disorders" @default.
- Q81235405 P1433 Q81235405-06207500-A24F-40C9-9ECD-F40AF2F0976A @default.
- Q81235405 P1476 Q81235405-2A889A5E-BF9A-4A25-AF45-360267D9045E @default.
- Q81235405 P2093 Q81235405-BEB0D579-9899-4D36-BE81-9F2345600DD0 @default.
- Q81235405 P304 Q81235405-64AC42D2-E43E-4BB6-A60E-3BCB79DAFD3F @default.
- Q81235405 P31 Q81235405-9E5A91BC-9982-49B3-95DA-86333DC15698 @default.
- Q81235405 P356 Q81235405-FEE0A8D3-92FD-4149-A750-0AD0ED612833 @default.
- Q81235405 P433 Q81235405-926E09FC-4012-4A38-AE0D-5FBA708CB10F @default.
- Q81235405 P478 Q81235405-EE177245-1935-49A0-A9D9-49AE51863EA7 @default.
- Q81235405 P577 Q81235405-41C508B6-0615-4638-AA47-AF004EE4D1DE @default.
- Q81235405 P698 Q81235405-D0DDB320-470F-4D5E-AF6E-A6EF80B8BEF5 @default.
- Q81235405 P356 J.MEHY.2005.08.006 @default.
- Q81235405 P698 16171950 @default.
- Q81235405 P1433 Q5558534 @default.
- Q81235405 P1476 "Phosphodiesterase inhibitors may be indicated in the treatment of postulated vasoactive neuropeptide autoimmune fatigue-related disorders" @default.
- Q81235405 P2093 "Donald R Staines" @default.
- Q81235405 P304 "203-204" @default.
- Q81235405 P31 Q13442814 @default.
- Q81235405 P356 "10.1016/J.MEHY.2005.08.006" @default.
- Q81235405 P433 "1" @default.
- Q81235405 P478 "66" @default.
- Q81235405 P577 "2005-09-19T00:00:00Z" @default.
- Q81235405 P698 "16171950" @default.